St. Jude Medical is in the process of acquiring Nanostim, which will enable it to introduce a leadless pacemaker this year. The company also aims to release four other product lines. "[W]e expect steady improvement to the growth profile of our pacemaker business as we move through the remainder of 2013," CEO Daniel Starks said.

Related Summaries